You are here

MRSA

   Methicillin-Resistant Staph Aureous (MRSA)
  • synonyms: staph, Staphylococcus aureus, staph aureus, MRSA
  • may be hospital acquired (HA) or community associated (CA).
  • infections include skin, osteomyelitis, septic arthritis, endocarditis, meningitis, pneumonia
  • can be spread by direct contact, towels, sheets, wound dressings, clothes, workout areas, sports equipment, whirlpools
  • MRSA most often affects elbows and knees
  • Often appears as large, tender, aggresive pustule with an erythematous ring 
  • Associated with contact sports: football, wrestling, rugby. Often develops from simple abrasions.
  • Risk factors: artificial turf, skin abrasion, shaving of skin, sharing towels or equipement, high body mass index, improperly cleaned team whirlpools.
  • Diagnosed by wound culture with antibiotic susceptibilities
  • Treatment = Incision and drainage and antibiotics
  • Empiric Treatment: Bactrim DS 1tab PO BID (8-12mg TMP/40-60SMX per kg/day divided BID for Peds); Doxyxycline 100mg PO BID(do not use in peds); Clindamycin 300-450mg PO QID (10-20mg/kg/day divided QID for PEDS); consider adding rifampin.
  • Definitive antiobiotic treatment should be based on culture susceptibilities, consider Infectious disease consultation when available.
  • HA-MRSA first line antibiotics: Vancomycin, consider gentamicin or rifampin for synergy. Other agents = daptomycin, linexolid, tigecycline, bactrim.
  • CA-MRSA first line antibiotics: doxycycline or clindamycin, or bactrim.
  • MRSA Prevention: no equipement sharing between players, no sharing towels, routine cleaning of all whirlpools / shared resources, athletes should pre-scrub with chlorhexidine soaps prior to whirlpool use, all open wounds should be occlusively dressed during practice and games, 
  • MRSA Osteomyelitis in Children: 4 independent predictors (temperature > 38.0 C, white blood-cell count > 12000 cells/µL, hematocrit < 34%, and C-reactive protein > 13 mg/L) can differentiate between MRSA and MSSA osteomyelitis. The predicted probability of MRSA osteomyelitis is 92% if all 4 predictors are present, 45% if 3 are present, 10% if 2 are present, 1% if 1 predictor is present.  (Ju KL, J Bone Joint Surg Am. 2011 Sep 21;93(18):1693-701).

Preoperative screening for MRSA (MRSA Screening)

  • nasal cultures may be performed by swabbing a sterile saline solution-moistened polyester (Dacron) swab for 5 seconds along the interior naris. 
  • 22.6% of patients are MSSA carriers; 4.4% are MRSA carriers. (Kim DH, JBJS 2010;92:1820)

MRSA Decolinization

  • MRSA & MSSA decolinization = intranasal 2% mupirocin ointment (Bactroban) applied to the interior of each naris twice daily for 5 days and shower wash with 2% clorhexidine daily for 5 days.
    -eradication may reduce infection rates from 0.45% without eradication to 0.19% with eradication.  (Kim DH, JBJS 2010;92:1820)
  • If MRSA carrier, vancomycin used as perioperative prophylactic antibiotic.  Vancomycin 15mg/kg started in holding and completed prior to beginning of procedure, with cefazolin 2 or 3 grams at time of “time-out”.
  • MRSA carriers (anterior nares) are 2-9 times more likely to develop surgical site infections than noncarriers
  • Consider pre-op for: immunocompromised, recent nursing home/hospital admission, antibiotic exposure within 1 yr.
  • Options: Chorhexicine 2% topical wash QD for 3-7 days: Doxycycline 100mg PO BID x 7 days: Mupirocin 1cm applied to nares TID for 5-7 days: Providone-Iodine 5% 4x per day for 5 days: Rifampin 300mg PO BID x7days.
  • Larkin S, Orthopedics 2008;31:37

MRSA Return to Play - Sports

  • Athletes can return to contact sports when no new lesions develop for 48 hours and they have been treated with antibiotics for 72 hours. (OKU-11)
  •  All wounds must be covered with bioocclusive prewrap and tape. 

MRSA References

  • Kirkland EB, Adams BB. Methicillin-resistant Staphylococcus aureus and athletes. J Am Acad Dermatol. 2008 Sep;59(3):494-502. 

  • Rihn JA, Michaels MG, Harner CD. Community-acquired methicillin-resistant staphylococcus aureus: an emerging problem in the athletic population. Am J Sports Med. 2005 Dec;33(12):1924-9.

Disclaimer

The information on this website is intended for orthopaedic surgeons.  It is not intended for the general public. The information on this website may not be complete or accurate.  The eORIF website is not an authoritative reference for orthopaedic surgery or medicine and does not represent the "standard of care".  While the information on this site is about health care issues and sports medicine, it is not medical advice. People seeking specific medical advice or assistance should contact a board certified physician.  See Site Terms / Full Disclaimer